Moderate

Brucellosis (undulant fever; Malta fever; Brucella melitensis/abortus)

Undulant fever + sweats + arthralgia + animal/raw-dairy contact; prolonged combination abx · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Zoonotic infection from Brucella via unpasteurised dairy, infected livestock or occupational exposure (farmers, vets, abattoir, lab). Protean: undulant fever, drenching sweats, arthralgia/back pain, hepatosplenomegaly; may become chronic/focal (sacroiliitis, spondylitis, epididymo-orchitis, endocarditis, neurobrucellosis). Needs prolonged COMBINATION antibiotics to prevent relapse. Endemic in India, Middle East, Mediterranean.

Red flags

  • New murmur / heart failure - brucella endocarditis (main cause of death)
  • Severe back pain with neurology - spondylitis / epidural involvement
  • Headache, meningism, cranial neuropathy, behavioural change - neurobrucellosis
  • Pancytopenia, pregnancy (miscarriage risk)

Assessment

Differential diagnosis

  • Enteric fever, malaria, TB
  • Lymphoma / haematological malignancy
  • Connective tissue disease / vasculitis
  • Infective endocarditis (other)
  • Mechanical/TB back pain (vs brucellar spondylitis)

Investigations

  • Blood cultures (prolonged incubation; alert lab to suspected Brucella - biohazard) +/- bone marrow culture (higher yield)
  • Serology: Brucella agglutination (SAT) titre >=1:160 or rising; ELISA IgM/IgG
  • FBC (cytopenias), LFTs (mild transaminitis), CRP/ESR
  • Imaging for focal disease: MRI spine/sacroiliac joints; echocardiography if endocarditis suspected; LP if neurobrucellosis
  • Inform laboratory (significant lab-acquisition risk - handle in containment)

Management

  • Confirm with cultures/serology; warn the lab of biohazard
  • Start prolonged combination antibiotic therapy (monotherapy relapses)
  • Assess for focal/complicated disease (spondylitis, neurobrucellosis, endocarditis) - these need longer and/or triple therapy +/- surgery
  • Counsel on source avoidance (pasteurise dairy, animal handling PPE); occupational/public-health notification where applicable
  • Arrange prolonged follow-up (serology, clinical) to detect relapse

Drugs & doses

Uncomplicated (WHO/expert): doxycycline 100 mg PO BD 6 weeks + streptomycin 1 g IM OD 2-3 weeks (most effective) OR + gentamicin 5 mg/kg IV/IM OD 7-10 days
All-oral alternative: doxycycline 100 mg BD 6 weeks + rifampicin 600-900 mg PO OD 6 weeks (slightly higher relapse)
Spondylitis/sacroiliitis: doxycycline + rifampicin + an aminoglycoside (initial) for >=12 weeks [verify local]
Neurobrucellosis: doxycycline + rifampicin + ceftriaxone 2 g IV BD for months, until CSF normalises
Endocarditis: doxycycline + rifampicin + aminoglycoside +/- ceftriaxone, prolonged, usually with valve surgery
Children <8y / pregnancy: co-trimoxazole-based combinations (e.g. co-trimoxazole + rifampicin) - avoid doxycycline/aminoglycoside as able [verify local dose]

Disposition

Uncomplicated disease: outpatient oral/IM combination therapy with ID follow-up. Admit for complicated/focal disease (endocarditis, neurobrucellosis, severe spondylitis), systemic illness, or pregnancy. Long-term follow-up for relapse.

Complications & pitfalls

  • Osteoarticular: sacroiliitis, spondylitis, peripheral arthritis
  • Neurobrucellosis (meningoencephalitis, radiculopathy)
  • Endocarditis (leading cause of brucellosis death)
  • Epididymo-orchitis, hepatosplenic abscess
  • Chronic brucellosis / relapse
  • Pregnancy loss

Exam pearls

  • Ask about unpasteurised dairy and animal/occupational contact in undulant fever with sweats and arthralgia
  • Monotherapy relapses - always use a combination for >=6 weeks (longer for focal disease)
  • Doxycycline + aminoglycoside outperforms doxycycline + rifampicin for relapse (Cochrane)
  • Alert the laboratory - Brucella is a notorious cause of laboratory-acquired infection
  • Suspect and specifically treat endocarditis, spondylitis and neurobrucellosis - they need intensified, prolonged therapy +/- surgery

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.